Bernard Cheung was educated at Sevenoaks School and the University of Cambridge, England. He was a British Heart Foundation Junior Research Fellow at Cambridge before taking up lectureships at the University of Sheffield and the University of Hong Kong.
In 2007-2009, he held the chair in Clinical Pharmacology and Therapeutics at the University of Birmingham, England. Currently, he is the Clinical Professor and Chief of the Division of Clinical Pharmacology in the Department of Medicine of the University of Hong Kong. He is also the Director of the Institute of Cardiovascular Science and Medicine.
Prof Cheung’s main research interest is in cardiovascular risk factors including hypertension and the metabolic syndrome. He is also interested in vasoactive peptides and clinical pharmacology issues. He is the Editor-in-Chief of the World Journal of Hypertension and Open Diabetes, and an Executive Editor of the Briti